{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:48:34Z","timestamp":1790236114601,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI121700"],"award-info":[{"award-number":["R21AI121700"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI050875"],"award-info":[{"award-number":["R01AI050875"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jconrel.2020.02.027","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T11:27:19Z","timestamp":1581679639000},"page":"442-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"special_numbering":"C","title":["Recent advances in nanotechnology-based drug delivery systems for the kidney"],"prefix":"10.1016","volume":"321","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3847-0492","authenticated-orcid":false,"given":"Fatemeh","family":"Oroojalian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Charbgoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1549-4886","authenticated-orcid":false,"given":"Maryam","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Amani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezvan","family":"Yazdian-Robati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4515-8675","authenticated-orcid":false,"given":"Ahad","family":"Mokhtarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.02.027_bb0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MNH.0b013e32831ec1db","article-title":"Angiogenesis in the kidney: a new therapeutic target?","volume":"18","author":"Lerman","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jconrel.2011.08.041","article-title":"Imatinib-ULS-lysozyme: a proximal tubular cell-targeted conjugate of imatinib for the treatment of renal diseases","volume":"157","author":"Dolman","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0015","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.addr.2010.07.011","article-title":"Drug targeting to the kidney: advances in the active targeting of therapeutics to proximal tubular cells","volume":"62","author":"Dolman","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0020","series-title":"Seminars in nephrology","first-page":"283","article-title":"The role of acute kidney injury in chronic kidney disease","author":"Hsu","year":"2016"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0025","article-title":"Mortality risk of chronic kidney disease: a comparison between the adult populations in urban China and the United States","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease\u2013a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0035","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0040","series-title":"Mortality and Global Health Estimates: Causes of Death; Projections for 2015\u20132030; Projection of Death Rates, in, Geneva","author":"W.H. Organization","year":"2018"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0045","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0140-6736(15)60126-X","article-title":"International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology","volume":"385","author":"Mehta","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/cpt.729","article-title":"Assessment of glomerular filtration rate in health and disease: a state of the art review","volume":"102","author":"Levey","year":"2017","journal-title":"Clin. Pharmacol. & Ther."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0055","doi-asserted-by":"crossref","DOI":"10.1051\/bmdcn\/2018080209","article-title":"The incidence of kidney cancer in Iran: a systematic review and meta-analysis","volume":"8","author":"Hassanipour","year":"2018","journal-title":"BioMedicine"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/ases.12635","article-title":"Recent advancements of robotic surgery for kidney cancer","volume":"11","author":"Phung","year":"2018","journal-title":"Asian J. Endoscopic Surg."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ajh\/hpx154","article-title":"Current concepts in the treatment of renovascular hypertension","volume":"31","author":"Herrmann","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0070","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2471\/BLT.17.206441","article-title":"The global burden of kidney disease and the sustainable development goals","volume":"96","author":"Luyckx","year":"2018","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ki.2011.380","article-title":"Treatment of chronic kidney disease","volume":"81","author":"Turner","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0080","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2013.10.050","article-title":"Clinical challenges in diagnosis and management of diabetic kidney disease","volume":"63","author":"Stanton","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0085","doi-asserted-by":"crossref","first-page":"17194","DOI":"10.1002\/jcb.28980","article-title":"Synthesis and evaluation of injectable thermosensitive penta-block copolymer hydrogel (PNIPAAm-PCL-PEG-PCL-PNIPAAm) and star-shaped poly (CL CO LA)-b-PEG for wound healing applications","volume":"120","author":"Oroojalian","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0090","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/21691401.2017.1376675","article-title":"Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment","volume":"46","author":"Afsharzadeh","year":"2018","journal-title":"Artificial cells, Nanomed. and Biotechnol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0095","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.2174\/1381612821666151027153410","article-title":"Synthetic and biological vesicular nano-carriers designed for gene delivery","volume":"21","author":"Soltani","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0100","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.kint.2016.03.041","article-title":"Nanomedicines for kidney diseases","volume":"90","author":"Williams","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.apsb.2013.12.005","article-title":"Kidney\u2013targeted drug delivery systems","volume":"4","author":"Zhou","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/med.21532","article-title":"Targeting strategies for drug delivery to the kidney: from renal glomeruli to tubules","volume":"39","author":"Liu","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0115","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.3390\/ph3113371","article-title":"Nanomedicine faces barriers","volume":"3","author":"Debbage","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0120","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrneph.2016.156","article-title":"Nanomedicines for renal disease: current status and future applications","volume":"12","author":"Kamaly","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0125","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/jps.2600730934","article-title":"Distribution and elimination of polymethyl methacrylate nanoparticles after peroral administration to rats","volume":"73","author":"Nefzger","year":"1984","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0130","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.msec.2017.05.068","article-title":"Efficient megalin targeted delivery to renal proximal tubular cells mediated by modified-polymyxin B-polyethylenimine based nano-gene-carriers","volume":"79","author":"Oroojalian","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2017.03.024","article-title":"Megalin-targeted enhanced transfection efficiency in cultured human HK-2 renal tubular proximal cells using aminoglycoside-carboxyalkyl-polyethylenimine-containing nanoplexes","volume":"523","author":"Oroojalian","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0140","doi-asserted-by":"crossref","first-page":"F54","DOI":"10.1152\/ajprenal.00143.2016","article-title":"A kidney-selective biopolymer for targeted drug delivery","volume":"312","author":"Bidwell","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0145","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1039\/C7BM00271H","article-title":"Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease","volume":"5","author":"Wang","year":"2017","journal-title":"Biomaterials Sci."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0150","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00424-018-2150-z","article-title":"Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity model","volume":"470","author":"Diekj\u00fcrgen","year":"2018","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1208\/s12248-018-0248-z","article-title":"Nephrotoxicity and kidney transport assessment on 3D perfused proximal tubules","volume":"20","author":"Vormann","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0160","series-title":"Brenner and Rector's the Kidney E-Book","author":"Skorecki","year":"2015"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0165","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2215\/CJN.10391012","article-title":"Proximal tubule function and response to acidosis","volume":"9","author":"Curthoys","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0170","doi-asserted-by":"crossref","first-page":"F1187","DOI":"10.1152\/ajprenal.00185.2018","article-title":"Acid-base regulation in the renal proximal tubules: using novel pH sensors to maintain homeostasis","volume":"315","author":"Rajkumar","year":"2018","journal-title":"Am. J. Physiol.Renal Physiol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000453028","article-title":"Disorders of acid-base balance: new perspectives","volume":"2","author":"Seifter","year":"2016","journal-title":"Kidney Dis."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0180","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95107","article-title":"Renal tubule insulin receptor modestly promotes elevated blood pressure and markedly stimulates glucose reabsorption","volume":"3","author":"Nizar","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0185","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00125-018-4656-5","article-title":"Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2","volume":"61","author":"Ghezzi","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0190","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/nl504610d","article-title":"Mesoscale nanoparticles selectively target the renal proximal tubule epithelium","volume":"15","author":"Williams","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0195","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.ackd.2013.07.006","article-title":"Applications of nanoparticles in the detection and treatment of kidney diseases","volume":"20","author":"Brede","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0200","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ki.2012.20","article-title":"Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis","volume":"82","author":"Grgic","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0205","doi-asserted-by":"crossref","first-page":"F1054","DOI":"10.1152\/ajprenal.00650.2012","article-title":"Proximal tubule-specific overexpression of netrin-1 suppresses acute kidney injury-induced interstitial fibrosis and glomerulosclerosis through suppression of IL-6\/STAT3 signaling","volume":"304","author":"Ranganathan","year":"2013","journal-title":"Am. J. Physiol.Renal Physiol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0210","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.2174\/0929867325666180108100723","article-title":"Nano-scale gene delivery systems: current technology, obstacles, and future directions","volume":"25","author":"Garcia-Guerra","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0215","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Shah","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0220","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1021\/acs.molpharmaceut.6b00015","article-title":"Drug delivery research: the invention cycle","volume":"13","author":"Park","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0225","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/j.2040-4603.2011.tb00382.x","article-title":"Cyclooxygenase metabolites in the kidney","volume":"1","author":"Harris","year":"2011","journal-title":"Comprehensive Physiology"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7150\/thno.9717","article-title":"Chitosan\/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice","volume":"5","author":"Yang","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0235","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1021\/acsnano.5b00428","article-title":"Characterizing the interactions of organic nanoparticles with renal epithelial cells in vivo","volume":"9","author":"Nair","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0240","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/17435390.2015.1095364","article-title":"Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: uptake and toxicity in primary human tubular epithelial cells","volume":"10","author":"Cicha","year":"2016","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/HYPERTENSIONAHA.117.09843","article-title":"Selective nanoparticle targeting of the renal tubules","volume":"71","author":"Williams","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0250","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.biomaterials.2003.10.097","article-title":"The targeting of anionized polyvinylpyrrolidone to the renal system","volume":"25","author":"Kodaira","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0255","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.addr.2017.12.019","article-title":"Targeting renal fibrosis: mechanisms and drug delivery systems","volume":"129","author":"Nastase","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0260","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3892\/ijmm.2017.2902","article-title":"Albumin-based nanoparticles as methylprednisolone carriers for targeted delivery towards the neonatal fc receptor in glomerular podocytes","volume":"39","author":"Wu","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0265","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6305439","article-title":"Innate immune response in kidney ischemia\/reperfusion injury: potential target for therapy","volume":"2017","author":"Kezi\u0107","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1611391","article-title":"Epidemiology of acute kidney injury in critically ill children and young adults","volume":"376","author":"Kaddourah","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0275","article-title":"Cholesterol-conjugated PEGylated PAMAM as an efficient Nanocarrier for plasmid encoding Interleukin-12 Immunogene delivery towards Colon Cancer cells","author":"Pishavar","year":"2019","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0280","doi-asserted-by":"crossref","first-page":"39547","DOI":"10.18632\/oncotarget.17135","article-title":"Nanoparticle-mediated dual delivery of resveratrol and DAP5 ameliorates kidney ischemia\/reperfusion injury by inhibiting cell apoptosis and inflammation","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0285","doi-asserted-by":"crossref","first-page":"24154","DOI":"10.18632\/oncotarget.16530","article-title":"Berberine nanoparticles protects tubular epithelial cells from renal ischemia-reperfusion injury","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0290","doi-asserted-by":"crossref","first-page":"12","DOI":"10.23876\/j.krcp.2017.36.1.12","article-title":"The role of renal proximal tubule transport in the regulation of blood pressure","volume":"36","author":"Horita","year":"2017","journal-title":"Kidney Res. Clin. Practice"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0295","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/15734021113099990009","article-title":"Roles of renal proximal tubule transport in the pathogenesis of hypertension","volume":"9","author":"Horita","year":"2013","journal-title":"Curr. Hypertens. Rev."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0300","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/hr.2013.155","article-title":"Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension","volume":"37","author":"Olearczyk","year":"2014","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0305","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.freeradbiomed.2014.06.001","article-title":"Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration","volume":"73","author":"Savalia","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0310","first-page":"45","article-title":"Renal cell carcinoma: links and risks","volume":"9","author":"Kabaria","year":"2016","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0315","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3348\/kjr.2015.16.4.853","article-title":"Unusual malignant solid neoplasms of the kidney: cross-sectional imaging findings","volume":"16","author":"Karaosmano\u011flu","year":"2015","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0320","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nature reviews Disease primers"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0325","series-title":"Renal Cell Carcinoma: A Review of Biology and Pathophysiology, F1000Research, 7","author":"Nabi","year":"2018"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0330","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fphar.2016.00423","article-title":"Targeting strategies for renal cell carcinoma: from renal cancer cells to renal cancer stem cells","volume":"7","author":"Yuan","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0335","series-title":"Immuno-Oncology","first-page":"1","article-title":"Immunotherapies in early and advanced renal cell cancer","author":"Kasenda","year":"2015"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0340","first-page":"40","article-title":"Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes","volume":"6","author":"Devulapally","year":"2014","journal-title":"Wiley Interdisciplinary Rev.: Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0345","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1158\/1535-7163.MCT-17-0471","article-title":"HIF2\u03b1-targeted RNAi therapeutic inhibits clear cell renal cell carcinoma","volume":"17","author":"Wong","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0350","series-title":"Targeting the HGF-cMET Axis in Hepatocellular Carcinoma, International Journal of Hepatology, 2013","author":"Goff","year":"2013"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0355","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.nano.2016.04.002","article-title":"Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer","volume":"12","author":"Kulkarni","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0360","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/mp900243b","article-title":"Cancer therapies utilizing the camptothecins: a review of the in vivo literature","volume":"7","author":"Venditto","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0365","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/01635581.2013.749290","article-title":"Selective cytotoxicity and combined effects of camptothecin or paclitaxel with sodium-R-alpha lipoate on A549 human non-small cell lung cancer cells","volume":"66","author":"Ibrahim","year":"2014","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0370","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1158\/0008-5472.CAN-07-6532","article-title":"Novel SN-38\u2013incorporated polymeric micelle, NK012, strongly suppresses renal cancer progression","volume":"68","author":"Sumitomo","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0375","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/jps.24318","article-title":"Comparison of Sorafenib-loaded poly (lactic\/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma","volume":"104","author":"Liu","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0380","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac9647","article-title":"Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury","volume":"8","author":"Alidori","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0385","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2016.05.047","article-title":"Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors","volume":"509","author":"Kibria","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0390","doi-asserted-by":"crossref","first-page":"11550","DOI":"10.1038\/ncomms11550","article-title":"The fast-recycling receptor Megalin defines the apical recycling pathway of epithelial cells","volume":"7","author":"Bay","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0395","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1152\/physiol.00022.2012","article-title":"Endocytic receptors in the renal proximal tubule","volume":"27","author":"Christensen","year":"2012","journal-title":"Physiology"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0400","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrneph.2013.212","article-title":"Proteinuria: tubular handling of albumin\u2014degradation or salvation?","volume":"9","author":"Christensen","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0405","first-page":"1","article-title":"The fast-recycling receptor Megalin defines the apical recycling pathway of epithelial cells","volume":"7","author":"Bay","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0410","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.7150\/thno.7866","article-title":"Megalin-mediated specific uptake of chitosan\/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing","volume":"4","author":"Gao","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0415","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.matbio.2018.02.006","article-title":"Renal fibrosis: primacy of the proximal tubule","volume":"68","author":"Gewin","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0420","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1007\/s11095-007-9515-x","article-title":"Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis","volume":"25","author":"Prakash","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0425","first-page":"417","article-title":"Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells","volume":"7","author":"Dolman","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0430","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1016\/j.biomaterials.2014.04.106","article-title":"Kidney-specific drug delivery system for renal fibrosis based on coordination-driven assembly of catechol-derived chitosan","volume":"35","author":"Qiao","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0435","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.2147\/IJN.S166445","article-title":"Kidney-targeted drug delivery via rhein-loaded polyethyleneglycol-co-polycaprolactone-co-polyethylenimine nanoparticles for diabetic nephropathy therapy","volume":"13","author":"Chen","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0440","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1080\/10717544.2017.1410258","article-title":"Sialic acid-modified solid lipid nanoparticles as vascular endothelium-targeting carriers for ischemia-reperfusion-induced acute renal injury","volume":"24","author":"Hu","year":"2017","journal-title":"Drug delivery"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0445","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0304-3835(91)90082-S","article-title":"Inhibition of human renal cancer by monoclonal antibody targeted methotrexate-containing liposomes in an ascites tumor model","volume":"56","author":"Singh","year":"1991","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0450","first-page":"3976","article-title":"Targeting of methotrexate-containing liposomes with a monoclonal antibody against human renal cancer","volume":"49","author":"Singh","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0455","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/mol.107.034140","article-title":"Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium","volume":"72","author":"Asgeirsdottir","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0460","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2008.12.003","article-title":"Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes","volume":"370","author":"Zhu","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0465","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1002\/art.24026","article-title":"Anti\u2013\u03b18 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus","volume":"58","author":"Scindia","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0470","doi-asserted-by":"crossref","first-page":"F554","DOI":"10.1152\/ajprenal.00391.2007","article-title":"Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes","volume":"294","author":"\u00c1sgeirsd\u00f3ttir","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0475","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.7150\/thno.19571","article-title":"E-selectin-targeted sialic acid-PEG-dexamethasone micelles for enhanced anti-inflammatory efficacy for acute kidney injury","volume":"7","author":"Hu","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0480","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1007\/s12274-018-2100-2","article-title":"Design and in vivo characterization of kidney-targeting multimodal micelles for renal drug delivery","volume":"11","author":"Wang","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0485","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1021\/acsomega.6b00423","article-title":"Polymer nanoparticle engineering for podocyte repair: from in vitro models to new nanotherapeutics in kidney diseases","volume":"2","author":"Colombo","year":"2017","journal-title":"ACS omega"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0490","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nbt798","article-title":"Synthesis of a poly (vinylpyrrolidone-co-dimethyl maleic anhydride) co-polymer and its application for renal drug targeting","volume":"21","author":"Kamada","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0495","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.2147\/IJN.S146978","article-title":"Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium","volume":"12","author":"Tong","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0500","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1681\/ASN.2009030295","article-title":"siRNA-based therapy ameliorates glomerulonephritis","volume":"21","author":"Shimizu","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0505","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam6764","article-title":"Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys","volume":"9","author":"Tietjen","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0510","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.7150\/thno.15647","article-title":"Cancer theranostic nanoparticles self-assembled from amphiphilic small molecules with equilibrium shift-induced renal clearance","volume":"6","author":"Ma","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0515","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1103573108","article-title":"Targeting kidney mesangium by nanoparticles of defined size","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0520","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1681\/ASN.2014090853","article-title":"Store\u2013operated Ca2+ channels in mesangial cells inhibit matrix protein expression","volume":"26","author":"Wu","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0525","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1166\/jnn.2012.6372","article-title":"Kidney-specific peptide-conjugated poly (ester amine) for the treatment of kidney fibrosis","volume":"12","author":"Kim","year":"2012","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0530","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1073\/pnas.1200718109","article-title":"Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane","volume":"109","author":"Zuckerman","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0535","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/nat.2014.0505","article-title":"siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA","volume":"25","author":"Zuckerman","year":"2015","journal-title":"Nucleic acid therapeutics"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0540","doi-asserted-by":"crossref","first-page":"F1090","DOI":"10.1152\/ajprenal.00642.2016","article-title":"Negative regulation of Smad1 pathway and collagen IV expression by store-operated Ca2+ entry in glomerular mesangial cells","volume":"312","author":"Wu","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0545","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mabi.201100277","article-title":"Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue","volume":"12","author":"Dolman","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0550","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1681\/ASN.V122308","article-title":"Identification of receptor ligands by screening phage-display peptide libraries ex vivo on microdissected kidney tubules","volume":"12","author":"ODERMATT","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0555","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/bc300020f","article-title":"Peptide\u2013drug conjugate linked via a disulfide bond for kidney targeted drug delivery","volume":"23","author":"Geng","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0560","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1523-1755.2002.00120.x","article-title":"Selection of peptide ligands binding to the basolateral cell surface of proximal convoluted tubules","volume":"61","author":"Audig\u00e9","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0565","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/acs.bioconjchem.6b00057","article-title":"Renal targeting: peptide-based drug delivery to proximal tubule cells","volume":"27","author":"Wischnjow","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0570","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2008.08.013","article-title":"Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors","volume":"132","author":"Fretz","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0575","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/dmd.104.002808","article-title":"Renal-selective delivery and angiotensin-converting enzyme inhibition by subcutaneously administered captopril-lysozyme","volume":"33","author":"Prakash","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0580","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1124\/jpet.301.3.1139","article-title":"Targeting of captopril to the kidney reduces renal angiotensin-converting enzyme activity without affecting systemic blood pressure","volume":"301","author":"Kok","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0585","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1002\/smll.201200733","article-title":"Kidney podocytes as specific targets for cyclo (RGDfC)-modified nanoparticles","volume":"8","author":"Pollinger","year":"2012","journal-title":"small"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0590","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.9690.1","article-title":"Nanoparticle-based drug delivery systems: What can they really do in vivo?","volume":"6","author":"Wang","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0595","first-page":"20170845","article-title":"Manipulating nanoparticle transport within blood flow through external forces: an exemplar of mechanics in nanomedicine, proceedings of the Royal Society a: mathematical","volume":"474","author":"Ye","year":"2018","journal-title":"Phys. Eng. Sci."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0600","doi-asserted-by":"crossref","first-page":"25613","DOI":"10.1038\/srep25613","article-title":"Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury","volume":"6","author":"Lundy","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0605","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2018.08.039","article-title":"Encapsulation of Thermo-responsive gel in pH-sensitive Polymersomes as dual-responsive smart carriers for controlled release of doxorubicin","volume":"288","author":"Oroojalian","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0610","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0615","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jconrel.2018.01.002","article-title":"Gold nanoparticle should understand protein corona for being a clinical nanomaterial","volume":"272","author":"Charbgoo","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0620","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12989-017-0223-3","article-title":"Protein corona: implications for nanoparticle interactions with pulmonary cells","volume":"14","author":"Konduru","year":"2017","journal-title":"Particle and fibre toxicology"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0625","series-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","author":"Longmire","year":"2008"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0630","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1681\/ASN.2011080818","article-title":"Development of the renal arterioles","volume":"22","author":"Lopez","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0635","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5966\/sctm.2015-0429","article-title":"Direct isolation and characterization of human nephron progenitors","volume":"6","author":"Da Sacco","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0640","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00098.2016","article-title":"Nephron number, hypertension, and CKD: physiological and genetic insight from humans and animal models","volume":"49","author":"Wang","year":"2017","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0645","series-title":"Harrison's Nephrology and Acid-Base Disorders, 2e","author":"Jameson","year":"2013"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0650","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/stem.2699","article-title":"Concise review: kidney generation with human pluripotent stem cells","volume":"35","author":"Morizane","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0655","series-title":"Brenner and Rector's the Kidney E-Book","author":"Taal","year":"2011"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0660","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/17460441.2015.1033394","article-title":"Designing drugs that combat kidney damage","volume":"10","author":"Ramos","year":"2015","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0665","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0670","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0675","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.yexcr.2012.02.031","article-title":"The glomerular basement membrane","volume":"318","author":"Miner","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0680","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.ackd.2013.06.003","article-title":"Targeting therapeutics to the glomerulus with nanoparticles","volume":"20","author":"Zuckerman","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0685","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2215\/CJN.09400913","article-title":"The glomerulus: the sphere of influence","volume":"9","author":"Pollak","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0690","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/00365513.2015.1025427","article-title":"Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome:\u2018shrunken pore syndrome\u2019","volume":"75","author":"Grubb","year":"2015","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0695","first-page":"1","article-title":"An update on LDL apheresis for nephrotic syndrome","author":"Raina","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0700","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/jcm7090265","article-title":"Idiopathic nephrotic syndrome: characteristics and identification of prognostic factors","volume":"7","author":"Dumas De La Roque","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0705","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2040-2384-2-14","article-title":"Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability","volume":"2","author":"Sarin","year":"2010","journal-title":"J. Angiogenes. Res."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0710","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1681\/ASN.2010020199","article-title":"Imaging of the porous ultrastructure of the glomerular epithelial filtration slit","volume":"21","author":"Gagliardini","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0715","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/9780470185834.ch16","article-title":"Nanostructures for cancer diagnostics and therapy","author":"Soppimath","year":"2007","journal-title":"Biomedical nanostructures"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0720","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1039\/C8NH00010G","article-title":"Reassessment of long circulation via monitoring of integral polymeric nanoparticles justifies a more accurate understanding","volume":"3","author":"He","year":"2018","journal-title":"Nanoscale Horizons"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0725","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10439-012-0630-4","article-title":"Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model","volume":"41","author":"Stylianopoulos","year":"2013","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0730","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/nano9030371","article-title":"Nanomaterials for drug delivery to the central nervous system","volume":"9","author":"Teleanu","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0735","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2015.04.017","article-title":"Surface modification and local orientations of surface molecules in nanotherapeutics","volume":"207","author":"Amin","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0740","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrd4503","article-title":"A holistic approach to targeting disease with polymeric nanoparticles","volume":"14","author":"Cheng","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0745","doi-asserted-by":"crossref","first-page":"8858","DOI":"10.1039\/C7NR02977B","article-title":"Visualization of the protein corona: towards a biomolecular understanding of nanoparticle-cell-interactions","volume":"9","author":"Kokkinopoulou","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0750","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-3155-11-26","article-title":"Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle","volume":"11","author":"Saptarshi","year":"2013","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0755","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0760","doi-asserted-by":"crossref","first-page":"22103","DOI":"10.1021\/acs.jpcc.6b08362","article-title":"Shape-dependent Relaxivity of nanoparticle-based T 1 magnetic resonance imaging contrast agents","volume":"120","author":"Culver","year":"2016","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0765","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1021\/acs.nanolett.6b02577","article-title":"The effect of cage shape on nanoparticle-based drug carriers: anticancer drug release and efficacy via receptor blockade using dextran-coated iron oxide nanocages","volume":"16","author":"Rampersaud","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0770","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2010.10.025","article-title":"Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers","volume":"150","author":"Calderon","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0775","series-title":"Advanced Materials Research, Trans Tech Publ","first-page":"332","article-title":"Electromechanical properties of vertically aligned carbon nanotube","author":"Rashidi","year":"2013"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0780","doi-asserted-by":"crossref","first-page":"0069","DOI":"10.1038\/s41551-017-0069","article-title":"Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip","volume":"1","author":"Musah","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0785","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.mattod.2013.11.003","article-title":"Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology","volume":"16","author":"Liu","year":"2013","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0790","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1416","article-title":"Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials","volume":"9","author":"Caster","year":"2017","journal-title":"Wiley Interdisciplinary Rev. Nanomed. and Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0795","first-page":"742","article-title":"Progress in nanomedicine: approved and investigational nanodrugs","volume":"42","author":"Ventola","year":"2017","journal-title":"Pharmacy and Therapeutics"},{"key":"10.1016\/j.jconrel.2020.02.027_bb0800","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1208\/s12248-016-9970-6","article-title":"Where are the nanodrugs? An industry perspective on development of drug products containing nanomaterials","volume":"18","author":"Havel","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2020.02.027_bb0805","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920301176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920301176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:50:44Z","timestamp":1759161044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920301176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":161,"alternative-id":["S0168365920301176"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.02.027","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in nanotechnology-based drug delivery systems for the kidney","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}